Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Outerwall Q1 Profit From Cont. Ops. Decreases; Raises 2014 Earnings Guidance

RELATED NEWS
Trade OUTR now with 

Outerwall Inc. (OUTR: Quote) reported that its first-quarter income from continuing operations decreased to $23.89 million or $0.96 per share, from $28.01 million or $0.97 per share, last year. The company said the decrease in income from continuing operations was primarily due to increased interest expense related to the $350.0 million in Senior Notes issued on March 12, 2013 and an increased loss from equity method investments.

Total earnings pers share was $0.94, compared to $0.78, previous year. Core earnings per share from continuing operations was $1.27 for the quarter.

On average, ten analysts polled by Thomson Reuters expected the company to report profit per share of $0.93 for the quarter. Analysts' estimates typically exclude special items. Revenue increased to $600.37 million from $573.31 million. Analysts expected revenue of $586.65 million for the qauarter. The company said its year-over-year revenue growth was primarily due to the inclusion of the ecoATM business that the company acquired on July 23, 2013, and an increase in same store sales and newly installed and relocated kiosks in both the Redbox and Coinstar lines of business.

For 2014, the company expects: consolidated revenue between $2.378 billion and $2.488 billion; and core EPS from continuing operations between $6.68 and $7.18. Analysts expect the company to report 2014 profit per share of $6.20 on revenue of $2.41 billion.

For the second quarter, the company expects: consolidated revenue between $546 million and $576 million; and core EPS from continuing operations between $1.24 and $1.44. Analysts expect the company to report second-quarter profit per share of $1.54 on revenue of $591.56 million.

Register
To receive FREE breaking news email alerts for Outerwall Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.